Avita Medical Inc. ( RCEL) - Key Metrics
RCEL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.71 | -$0.25 | -$0.11 | -$0.12 |
| 2026Q1 | $0.66 | -$0.36 | -$0.34 | -$0.34 |
| 2025Q4 | $0.58 | -$0.38 | -$0.18 | -$0.12 |
| 2025Q3 | $0.60 | -$0.46 | -$0.18 | -$0.22 |
| 2025Q2 | $0.70 | -$0.38 | -$0.39 | -$0.41 |
RCEL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.13 |
| 2026Q1 | 0% | -2.57 |
| 2025Q4 | 0% | -2.27 |
| 2025Q3 | 0% | -2.78 |
| 2025Q2 | 0% | -3.48 |
RCEL
Price: $13.33
52 week price:
Earnings Per Share: -1.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 159000
Market Capitalization: 316.0 million